In acute lymphoblastic leukemia (ALL), hypermethylation of the AHR promoter was found in 33% of patients and impaired binding of SP1 resulting in AHR transcriptional silencing [194]. This evidence concerns the gene AHR and acute lymphoblastic leukemia.